New immune-based treatment approach: trial recruiting in San Francisco.
A clinical trial of a new kind of immune-based treatment--using a drug widely available in Japan for other purposes--is now recruiting in San Francisco.
James
J S
JS
D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008055:Lipids / Q000627:therapeutic use*; D008351:Mannans / Q000627:therapeutic use*; D018579:Patient Selection; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012495:San Francisco; D019562:Viral Load; D015215:Zidovudine
D008055:Lipids; D008351:Mannans; D010919:Placebos; C031208:specific substance maruyama; D015215:Zidovudine